Michael R. Hayden - 30 Mar 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Michael R. Hayden
Issuer symbol
ETNB
Transactions as of
30 Mar 2022
Net transactions value
+$1,077,914
Form type
4
Filing time
30 Mar 2023, 16:26:36 UTC
Previous filing
10 Dec 2021
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Purchase $22,625 +6,250 +8% $3.62 83,978 30 Mar 2022 See footnote F1
transaction ETNB Common Stock Purchase $34,750 +10,000 +12% $3.48 93,978 07 Apr 2022 See footnote F1
transaction ETNB Common Stock Purchase $26,700 +10,000 +11% $2.67* 103,978 25 Apr 2022 See footnote F1, F2
transaction ETNB Common Stock Purchase $993,839 +61,538 $16.15 61,538 28 Mar 2023 See footnote F3
holding ETNB Common Stock 80,904 30 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held directly by Genworks 2 Consulting Inc., over which the Reporting Person's wife has sole voting and investment power.
F2 This transaction was executed in multiple trades at prices ranging from $2.6499 to $2.699. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 These shares are held directly by The Hayden Family Trust, over which the Reporting Person's wife has sole voting and investment power.